While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Serum levels of C1M, a biochemical marker of type I collagen degradation, may predict progression of total joint damage in ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

Dividned stocks: 15 small-cap stocks have given dividends of up to ₹200 in the last 12 months, resulting in a dividend yield ...

Our warm weather season is short, and it's important to enjoy the outdoors. The point isn't to be sun-scared — just stay ...

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, ...

New York City’s housing shortage may find an unlikely hero in its glut of underused office buildings, according to Brad ...

Global companies have been hit with a brutal $320 billion in lost profit since 2017, and it has nothing to do with bad ...

A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...

Healthcare stocks now trade for 16 times forward earnings, compared to 30 for technology and 22 for the S&P 500 index. Most sectors are cheap versus their 10- and 30-year averages ...